The competition between HSA and S100A8/S100A9 for Aβ likely contributes to the Aβ-HSA imbalance in the pro-inflammatory conditions in AD favoring elevated S100A8/S100A9 levels. This evidence concerns the gene S100A9 and Alzheimer disease.